Proteomic Study Revealed a Distinction Between Human Dermal Fibroblasts and Mesenchymal Stem Cells from Different...

Area of Science:

• Regenerative Medicine
• Cell Biology
• Proteomics

Background:

• Mesenchymal stem cells (MSCs) are crucial for cell-based therapies, with tissue origin influencing their efficacy.
• Human dermal fibroblasts (HDFa) exhibit MSC-like properties, prompting investigation into their functional equivalence.
• Comparing HDFa with dental pulp stem cells (DPSCs) and adipose-derived mesenchymal stem cells (AD-MSCs) is vital for understanding cell source impact.

Purpose of the Study:

• To comparatively analyze the proteomic and phenotypic profiles of HDFa, DPSCs, and AD-MSCs.
• To identify protein signatures and signaling pathways differentiating these cell types.
• To evaluate the potential of HDFa as an alternative to MSCs in regenerative medicine.

Main Methods:

• Proteomic analysis using nano liquid chromatography and mass spectrometry.
• Phenotypic characterization including morphology, cell surface markers, and differentiation capacity.
• Gene Ontology (GO) term enrichment and Gene Set Enrichment Analysis (GSEA) for pathway identification.

Main Results:

• HDFa, DPSCs, and AD-MSCs displayed similarities and differences in morphology, markers, and differentiation.
• Proteomic analysis identified 3,051 proteins, with 86 differentially abundant proteins defining cell-type specific signatures.
• HDFa showed downregulated pathways in cell migration, adhesion, and Wnt signaling compared to DPSCs; AD-MSCs were associated with angiogenesis.

Conclusions:

• HDFa represent a potential alternative to MSCs but may exhibit inferior performance in defect repair models compared to DPSCs.
• AD-MSCs appear more suitable for angiogenesis-related applications than DPSCs.
• Proteomic and phenotypic profiling provides insights into cell source-specific functional characteristics for regenerative medicine.